Patents by Inventor Wayne K. Herber

Wayne K. Herber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CLOSTRIDIUM HISTOLYTICUM ENZYMES AND METHODS FOR THE USE THEREOF
    Publication number: 20250222080
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Application
    Filed: March 28, 2025
    Publication date: July 10, 2025
    Inventor: Wayne K. HERBER
  • Pharmaceutical compositions comprising collagenase I and collagenase II
    Patent number: 12263209
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: October 25, 2024
    Date of Patent: April 1, 2025
    Assignee: ENDO BIOLOGICS LIMITED
    Inventor: Wayne K. Herber
  • PHARMACEUTICAL COMPOSITIONS COMPRISING COLLAGENASE I and COLLAGENASE II
    Publication number: 20250041391
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 6, 2025
    Inventor: Wayne K. HERBER
  • NUCLEIC ACID MOLECULES ENCODING CLOSTRIDIUM HISTOLYTICUM COLLAGENASE I AND METHODS OF PRODUCING THE SAME
    Publication number: 20240269245
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Application
    Filed: March 25, 2024
    Publication date: August 15, 2024
    Inventor: Wayne K. Herber
  • Clostridium Histolyticum Enzymes And Methods For The Use Thereof
    Publication number: 20240252602
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Application
    Filed: June 28, 2023
    Publication date: August 1, 2024
    Inventor: Wayne K. Herber
  • Nucleic acid molecules encoding clostridium histolyticum collagenase I and methods of producing the same
    Patent number: 11975054
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: May 7, 2024
    Assignee: ENDO GLOBAL VENTURES
    Inventor: Wayne K. Herber
  • Nucleic acid molecules encoding clostridium histolyticum collagenase II and methods of producing the same
    Patent number: 11879141
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: June 28, 2023
    Date of Patent: January 23, 2024
    Assignee: Endo Global Ventures
    Inventor: Wayne K. Herber
  • Clostridium Histolyticum Enzymes And Methods For The Use Thereof
    Publication number: 20230416717
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Application
    Filed: June 28, 2023
    Publication date: December 28, 2023
    Inventor: Wayne K. Herber
  • Clostridium Histolyticum Enzymes and Methods for the Use Thereof
    Publication number: 20200206326
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Inventor: Wayne K. Herber
  • Clostridium histolyticum enzymes and methods for the use thereof
    Patent number: 10603365
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: March 31, 2020
    Assignee: ENDO GLOBAL VENTURES
    Inventor: Wayne K. Herber
  • Clostridium Histolyticum Enzymes and Methods for the Use Thereof
    Publication number: 20180055918
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Application
    Filed: August 4, 2017
    Publication date: March 1, 2018
    Inventor: Wayne K. Herber
  • Clostridium histolyticum enzymes and methods for the use thereof
    Patent number: 9757435
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: September 12, 2017
    Assignee: ENDO GLOBAL VENTURES
    Inventor: Wayne K. Herber
  • Clostridium Histolyticum Enzymes and Methods for the Use Thereof
    Publication number: 20150010532
    Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.
    Type: Application
    Filed: July 11, 2014
    Publication date: January 8, 2015
    Inventor: Wayne K. Herber
  • Culture medium for Saccharomyces cerevisiae
    Patent number: 5795771
    Abstract: A synthetic culture medium for the growth of recombinant yeast and the production of recombinant proteins. The medium is useful for the growth of Saccharomyces cerevisiae which comprises per liter about 10 g ammonium sulfate, about 10 g potassium phosphate, about 0.5 g calcium chloride, about 0.5 g sodium chloride, about 3 g magnesium sulfate, about 0.25 g L-tyrosine, about 0.1 g choline, between about 1 and about 100 g carbon source, between about 50-150 mL amino acid cocktail, about 30 mL vitamin solution, about 20 mL trace element solution and about 0.3 mL UCON LB-625 antifoaming agent. Further, the vitamin solution contains biotin, pantothenate, myo-inositol, pyridoxine and thiamine.
    Type: Grant
    Filed: April 8, 1996
    Date of Patent: August 18, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Hugh George, Wayne K. Herber
  • Method of clonal growth of Streptococcus pneumoniae
    Patent number: 5314822
    Abstract: A culture medium containing no complex animal components is useful for production of bacteria and inoculum development from which pharmaceutically important products are to be isolated.
    Type: Grant
    Filed: October 15, 1992
    Date of Patent: May 24, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Fred J. Bailey, Wayne K. Herber